Collagen wound healing matrices and process for their production
US5024841A · kind A · utility
180Cited by
17References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 1988 |
| Grant date | Jun 18, 1991 |
| Priority date | — |
| Expiry date | Jun 30, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S128/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm.sup.3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves as an effective sustained delivery system for bioactive agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.